drugset / Trial / NCT00655109

A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

NCT00655109

Phase 4 Completed 60 enrolled Greiner, Jack V., OD DO PhD
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis

Timeline

Start
2008-02
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified Intranasal
Comparator Olopatadine Other / unclassified Other

Indications